NA Molecular Diagnostic Market Size, Share & Report 2031

NA Molecular Diagnostic Market Size, Share & Report 2031

Segments - North America Molecular Diagnostic Market by Technologies (PCR, In Situ Hybridization, Sequencing, Chips & Microarrays, Mass Spectrometry, and Others), Applications (Blood Screening, Infectious Disease, Human Leukocyte Antigen Typing, Oncology, Genetics, Pharmacogenomics, and Microbiology), Products (Reagent, Instrument, and Others), End-users (Laboratories, Hospitals, and Others), and Geography (North America) – North America Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2011 | 4.5 Rating | 66 Reviews | 214 Pages | Format : PDF Excel PPT

Report Description


North America Molecular Diagnostic Market Outlook

The North America Molecular Diagnostic Market size was valued at USD 9.50 Billion in 2022 and is expected to surpass USD 16.93 Billion by 2031, expanding at a CAGR of 6.63% during the forecast period, 2023 – 2031. Growth of the market is attributed to rapid urbanization, increasing overall efficiency & productivity for enterprises, and increasing demand for point of care diagnostics.

The biological indicators in the genome & proteome identification the molecular diagnostics techniques are used. To analyze as a protein how cells show their genes in medical testing by applying molecular biology. In agricultural biosecurity, detect risk, diagnose & monitor disease, and to identify which medicines & therapies good for individual patients the molecular diagnostics technique is used.

North America Molecular Diagnostic Market Outlook

The Covid-19 pandemic affected the demand and supply of North America molecular diagnostic market.

Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing use of molecular diagnostics equipment in laboratories is projected to boost the market.

  • Rapid innovations in molecular diagnostics technologies are the major factor fueling the market.

  • Lack of awareness about the molecular diagnostics devices is projected to restrict the market expansion during the forecast period.

  • High price of equipment’s is anticipated to hamper the market growth in the coming years.

  • R&D investment and technological advancement in small UAV market is projected to offer lucrative opportunities for the market players

Scope of the North America molecular diagnostic Market Report

The report on the North America molecular diagnostic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Molecular Diagnostic Market– North America  Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Technologies (PCR, In Situ Hybridization, Sequencing, Chips & Microarrays, Mass Spectrometry, and Others), Applications (Blood Screening, Infectious Disease, Human Leukocyte Antigen Typing, Oncology, Genetics, Pharmacogenomics, and Microbiology), Products (Reagent, Instrument, and Others), End-users (Laboratories, Hospitals, and Others)

Geographical Scope

United States, Canada, Mexico, and Rest of the North America

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Qiagen; Illumina, Inc.; F. Hoffmann-la Roche Ltd.; Danaher Corp.[Cepheid Inc.]; Agilent Technologies; EXACT Sciences Corp.; Abbott Laboratories; Becton, Dickinson & Company; Hologic Corp.; and Myriad Genetics, Inc.

North America Molecular Diagnostic Market Segment Insights

The oncology segment accounts for key share of the market

On the basis of applications, the North America molecular diagnostic market is fragmented into blood screening, infectious disease, human leukocyte antigen typing, oncology, genetics, pharmacogenomics, and microbiology.

The oncology segment accounts for a key share of the market. Growth of the market is attributed to rising industrialization and increasing research & development activities in molecular diagnostics equipment.

However, the infectious disease segment is anticipated to expand at a rapid pace during the forecast period due to increasing per capita income, rapid advancement in pharmacogenomics, and increasing number of infectious diseases.

The PCR segment is anticipated to hold significant market share

Based on technologies, the market is divided into PCR, in situ hybridization, sequencing, chips & microarrays, mass spectrometry, and others. The PCR segment accounts for a significant share of the market. Growth of the market is attributed to rising prevalence of chronic diseases, identification of diseases in early stages, and rising awareness among people.

The mass spectrometry is anticipated to expand at a rapid pace during the forecast period due to factors such as rising investment by government & private sectors, rapidly growing population, and increasing spending on healthcare expenditure.

North America Molecular Diagnostic Market Technologies

The instrument segment accounts for key share of the market

On the basis of products, the North America molecular diagnostic market is segmented into reagent, instrument, and others. The instrument segment accounts for a key share of the market.

Growth of the market is attributed to rapid economic growth and rising demand for polymerase chain reaction tests. The reagent segment is anticipated to expand at a rapid pace during the forecast period due to increasing identification of minimal residual diseases, presence of major market players, and rapid industrialization.

North America Molecular Diagnostic Market Products

The hospital segment accounts for significant share of the market

Based on end-users, the North America molecular diagnostic market is classified into laboratories, hospitals, and others. The oncology segment accounts for a significant share of the market.

Growth of the market is attributed to increasing research & development activities in molecular diagnostics equipment. The laboratories segment is anticipated to expand at a rapid pace during the forecast period due to increasing healthcare expenditure.

United States is estimated to hold major market share

On the basis of region, the North America molecular diagnostic market is categorized as United States, Canada, Mexico, and Rest of the North America. The market of Canada is estimated to expand at a high CAGR during the forecast period due to factors such as increasing prevalence of chronic diseases and increasing number of viral & bacterial outbreaks.

The market of United States is estimated to hold major market share due to rapid development in healthcare infrastructure and rapid innovations in technologies.

Segments

Technologies

  • PCR
  • In Situ Hybridization
  • Sequencing
  • Chips & Microarrays
  • Mass Spectrometry
  • Others

Applications

  • Blood Screening
  • Infectious Disease
  • Human Leukocyte Antigen Typing
  • Oncology
  • Genetics
  • Pharmacogenomics
  • Microbiology

Products

  • Reagent
  • Instrument
  • Others

End-users

  • Laboratories
  • Hospitals
  • Others

Geography

  • North America

Key Players

  • Qiagen
  • Illumina, Inc.
  • F. Hoffmann-la Roche Ltd.
  • Danaher Corp.[Cepheid Inc.]
  • Agilent Technologies
  • EXACT Sciences Corp.
  • Abbott Laboratories
  • Becton, Dickinson & Company
  • Hologic Corp.
  • Myriad Genetics, Inc.

Competitive Landscape

Key players competing in the North America molecular diagnostics market include Qiagen; Illumina, Inc.; F. Hoffmann-la Roche Ltd.; Danaher Corp.[Cepheid Inc.]; Agilent Technologies; EXACT Sciences Corp.; Abbott Laboratories; Becton, Dickinson & Company; Hologic Corp.; and Myriad Genetics, Inc.

Some of these players are using several market strategies such as collaborations, acquisitions, partnerships, merger, product launches, and capacity expansion to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

North America Molecular Diagnostic Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Diagnostic Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Molecular Diagnostic Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Molecular Diagnostic Market - Supply Chain
  4.5. Global Molecular Diagnostic Market Forecast
     4.5.1. Molecular Diagnostic Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Molecular Diagnostic Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Molecular Diagnostic Market Absolute $ Opportunity
5. Global Molecular Diagnostic Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Molecular Diagnostic Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Molecular Diagnostic Demand Share Forecast, 2019-2026
6. North America Molecular Diagnostic Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Molecular Diagnostic Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Molecular Diagnostic Demand Share Forecast, 2019-2026
7. Latin America Molecular Diagnostic Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Molecular Diagnostic Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Molecular Diagnostic Demand Share Forecast, 2019-2026
8. Europe Molecular Diagnostic Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Molecular Diagnostic Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Molecular Diagnostic Demand Share Forecast, 2019-2026
9. Asia Pacific Molecular Diagnostic Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Molecular Diagnostic Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Molecular Diagnostic Demand Share Forecast, 2019-2026
10. Middle East & Africa Molecular Diagnostic Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Molecular Diagnostic Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Molecular Diagnostic Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Molecular Diagnostic Market: Market Share Analysis
  11.2. Molecular Diagnostic Distributors and Customers
  11.3. Molecular Diagnostic Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Qiagen Illumina, Inc. F. Hoffmann-la Roche Ltd. Danaher Corp.[Cepheid Inc.] Agilent Technologies EXACT Sciences Corp.

Methodology

Our Clients

Nestle SA
Siemens Healthcare
Microsoft
Pfizer
The John Holland Group
General Mills
sinopec
FedEx Logistics